Clinical Audit Topics for Coronary Angiography and Angioplasty
Clinical audits in coronary angiography and angioplasty should focus on appropriateness of indications, procedural quality metrics, patient outcomes, and system efficiency to directly impact morbidity, mortality, and quality of life.
Based on the ACC/AHA guidelines 1 and contemporary practice standards 2, 3, here are specific audit topics organized by clinical priority:
Process and Appropriateness Audits
Indication Appropriateness
- Audit adherence to Class I, II, and III indications for coronary angiography across different clinical scenarios (stable angina, unstable coronary syndromes, post-MI risk stratification, preoperative evaluation) 1
- Review appropriateness of angiography timing in STEMI patients (door-to-balloon times, primary PCI vs. thrombolysis decisions) 1
- Evaluate use of non-invasive testing prior to angiography in stable patients to ensure proper risk stratification 1
- Assess frequency of "normal" coronary angiograms in STEMI presentations and alternative diagnoses identified 4
Pre-procedural Risk Assessment
- Audit calculation and documentation of STS risk scores for patients being considered for CABG 2
- Review SYNTAX score utilization in multivessel disease decision-making, acknowledging interobserver variability limitations 2
- Evaluate renal insufficiency screening and contrast nephropathy prevention protocols 1
Technical Quality Audits
Procedural Technique
- Measure reproducibility and interobserver variability in angiographic interpretation 1
- Audit completeness of angiographic reports including all desired elements (vessel dimensions, stenosis severity, collaterals, left ventricular function) 1
- Review use of adjunctive imaging (IVUS, intravascular Doppler, coronary angioscopy) and their appropriateness 1
- Assess vascular access site selection and complication rates 3
Restenosis and Follow-up
- Track angiographic and clinical restenosis rates after PCI, particularly comparing BMS vs. DES outcomes 1, 3
- Audit post-revascularization ischemia evaluation and management 1
Outcome Audits
Complications and Safety
- Monitor procedural complication rates including emergency surgery, subacute closure, renal insufficiency, vascular complications 1
- Track periprocedural enzyme elevation (CK levels) after catheter-based revascularization 1
- Evaluate no-reflow and slow-flow phenomena management 3
- Assess mortality rates for emergency PTCA and emergency bypass surgery 1
Patient-Centered Outcomes
- Measure survival rates post-procedure, stratified by ejection fraction and clinical presentation 1
- Audit return to employment rates post-revascularization 1
- Track quality of life improvements in angina reduction and functional capacity 3
System Efficiency Audits
Resource Utilization
- Evaluate appropriateness of outpatient vs. inpatient procedures based on patient selection criteria 5
- Audit discharge planning effectiveness from cardiology clinics, measuring discharge rates and follow-up appropriateness 6
- Review regional variation in coronary angiography utilization rates 1
- Assess cost-effectiveness comparing stress testing pathways vs. direct angiography 1
Workflow Optimization
- Measure time from stress test to angiography when indicated 1
- Audit ad hoc vs. staged angioplasty decision-making and outcomes 3
- Track unplanned hospitalizations after intended outpatient procedures 5
Special Population Audits
High-Risk Groups
- Evaluate outcomes in diabetic patients with multivessel disease (PCI vs. CABG decisions) 2
- Audit elderly patient outcomes and complication rates 1
- Review management of patients with left main stenosis and complexity stratification 2
- Assess outcomes in patients with systolic dysfunction or hibernating myocardium 1
Specific Clinical Scenarios
- Audit management of cardiac arrest survivors and sudden death survivors 1
- Review perioperative evaluation for noncardiac surgery patients 1
- Evaluate congenital heart disease patients undergoing angiography 1
Documentation and Reporting Audits
- Assess completeness of angiographic reports including vessel dimensions, stenosis quantification, collateral assessment, and left ventricular function 1
- Review documentation of informed consent and discussion of risks/benefits
- Audit adherence to CAD-RADS 2.0 reporting standards for standardized communication 7
Common Pitfalls to Avoid
When conducting these audits, avoid:
- Auditing Class III indications without context - some may be appropriate in specific circumstances
- Focusing solely on volume metrics without assessing appropriateness and outcomes
- Ignoring interobserver variability in angiographic interpretation, which can significantly affect audit results 1
- Failing to stratify by patient complexity when comparing outcomes across operators or institutions
The most impactful audits will be those that directly link process measures to patient outcomes (mortality, MI rates, repeat revascularization) rather than simply measuring adherence to documentation standards.